About Paradromics
Paradromics is a company based in Austin (United States) founded in 2015 by Andreas Schaefer. Paradromics has raised $88.66 million across 12 funding rounds from investors including HHS, NEOM and DARPA. Paradromics offers products and services including Connexus Brain-Computer Interface. Paradromics operates in a competitive market with competitors including Neuralink and Inner Cosmos, among others.
- Headquarter Austin, United States
- Founders Andreas Schaefer
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$88.66 M (USD)
in 12 rounds
-
Latest Funding Round
Not available
-
Investors
HHS
& 13 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Paradromics
Paradromics offers a comprehensive portfolio of products and services, including Connexus Brain-Computer Interface.
Records brain activity to enable communication for paralyzed individuals.
People of Paradromics
Unlock access to complete
Funding Insights of Paradromics
Paradromics has successfully raised a total of $88.66M across 12 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Paradromics
Paradromics has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, NEOM and DARPA.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A family investment office focused on venture and growth equity.
|
Locked | Locked | Locked | |
|
Venture capital fund focused on early-stage biotech, life sciences, IT, and multiple sectors
|
Locked | Locked | Locked | |
|
Private equity investments and corporate advisory services are managed.
|
Locked | Locked | Locked |
Investor details for Paradromics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Paradromics
Investment portfolio details for Paradromics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Paradromics
Detailed financials for Paradromics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paradromics Comparisons
Peer comparison for Paradromics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Paradromics
Paradromics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neuralink and Inner Cosmos, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable brain-computer interfaces are developed for thought-based device control.
|
|
| Locked | Locked | Locked |
AI-based implantable device for mood and addiction treatment is provided.
|
Detailed competitors of Paradromics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paradromics
Complete news archive for Paradromics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paradromics
Paradromics was founded in 2015.
Paradromics is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Paradromics is a funded company, having raised a total of $88.66M across 12 funding rounds to date.
Paradromics was founded in 2015 in Austin, United States, within the neurotechnology sector. Neural-machine interfaces are developed to enable bidirectional data transmission between the brain and external devices. Implanted electrodes are utilized to send and receive signals, supporting treatments for neurodegenerative diseases and facilitating connections for individuals with disabilities through prosthetic integration. Operations focus on high-volume data streaming capabilities.
Paradromics's top competitors include Neuralink and Inner Cosmos.
Paradromics offers Connexus Brain-Computer Interface.
Paradromics has 14 investors. Key investors include HHS, NEOM, DARPA, Prime Movers Lab, and Westcott Investment Group.